The appalling death of George Floyd on May 25, 2020, at the hands of the Minneapolis police in the USA has sparked large rallies and protests on a global scale. This lawless act of overt brutality is symbolic of structural and institutionalised racism in society. The causes are deep-rooted, complex, and multifactorial based on centuries of discrimination. But they are unacceptable, learned behaviours. They permeate all aspects of humanity, justice, and rights, with medicine and oncology certainly no exception. *The Lancet Oncology* comprises a small multicultural team of editors originating from several countries from around the world, but none of us are Black. We have seldom had to consider our skin colour as a determinant of what happens in our lives and can hardly imagine the consequences of such an indiscriminate and baseless notion, or the daily psychological trauma of confronting this issue.

On June 11, 2020, an [editorial](https://doi.org/10.1016/S0140-6736(20)31353-2){#interrefs10} in *The Lancet* stated that racism is a public health emergency of global concern. We echo this and go further---with specific reference to the African slave trade, this is a public health crisis that started in the 15th century, but one that society chose to ignore for generations despite very notable remonstrations, movements, and uprisings. One shocking statistic of current relevancy is that a Black man in some states in the USA nowadays has a higher chance of being killed by law enforcement than by COVID-19. This blatant racism, coupled with unconscious bias, perpetuates inequality in the USA and across the world. Among US oncologists, for example, just 2·3% self-identify as Black or African American, despite the fact that people of this ethnic origin account for 13% of the US population. On a broader scale, in 2018, just 5% of all active physicians in the USA were Black or African American, a mere 3·6% had university tenure, and 8·4% of applicants to medical school were Black or African American. These enormous disparities highlight the astounding scale of inequity.

In 2017, the American Society of Clinical Oncology (ASCO) published a [strategic plan](https://ascopubs.org/doi/full/10.1200/JCO.2017.73.1372){#interrefs20} for increasing racial and ethnic diversity in the oncology workforce. It proposed three objectives: 1) to establish a longitudinal pathway for increasing workforce diversity, 2) to enhance ASCO leadership diversity, and 3) to integrate a focus on diversity across ASCO programmes and policies. The ultimate goal was to achieve a workforce that reflects the demographics of the society it serves. Responding to the current crisis on June 3, 2020, the new ASCO President, [Lori Pierce](https://connection.asco.org/blogs/responding-racism-and-health-inequality-cancer-care-community){#interrefs30}, remarked, "we must commit the same energy and focus we pour in to conquering cancer to addressing the systemic issues that affect the health of people of colour...we must work together to enact meaningful change". A culturally diverse workforce makes a lot of sense, not just in terms of a fundamental fairness in society, but also from the perspective of having a better appreciation of the prevailing socioeconomic challenges and other factors among ethnic groups that affect access to health care and clinical trials, and treatment outcome. Having a more representative, multicultural workforce that understands these important distinctions improves care for all patients, irrespective of race or ethnic origin.

Journals also have a part to play in representing the interests of Black and ethnic minorities by ensuring fair representation in the media; highlighting disparities where they exist; educating readers on the underlying medical, scientific, and health system challenges specific to diverse peoples; championing change and an end to discrimination; and---crucially---listening and adapting to the community\'s needs. In the past two decades, *The Lancet Oncology* has published numerous Series and Commissions dedicated to these types of issues, but more can, and will, be done. Indeed, *The Lancet* has pledged solidarity with the Black Lives Matter movement and committed to turn this pledge into real actions through the material published, the work commissioned, and the people recognised in the pages of its many journals.

[WhiteCoats4BlackLives](https://whitecoats4blacklives.org){#interrefs40} is a US organisation run by medical students with a mission to eliminate racism in medicine and promote health and better lives for people of colour. They have three goals: to foster debate on racism as a public health concern, to end race discrimination in medical care, and to prepare future doctors to be advocates for racial justice. These very rational objectives underscore our collective need to support social justice and to value all human lives equally.
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